Court throws out Abbott AIDS-drug claims

Abbott Laboratories won a federal appeals court ruling dismissing claims that the company maintained a monopoly and overcharged for its HIV medicine Norvir, but still faces suits from competitors and drug-buyers over the price of the drug. Report